63 related articles for article (PubMed ID: 22494343)
1. Review of invasive cervical cancers and uptake of disclosure of results: an audit of procedures and response.
Prabakar I; Moss EL; Douce G; Parkes J; Redman CW
Cytopathology; 2012 Jun; 23(3):167-71. PubMed ID: 22494343
[TBL] [Abstract][Full Text] [Related]
2. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
Coleman DV; Poznansky JJ
Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
[TBL] [Abstract][Full Text] [Related]
3. Implementing the national invasive cervical cancer audit: a local perspective.
Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
[TBL] [Abstract][Full Text] [Related]
4. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
5. Disclosing the results of the invasive cervical cancer review to patients: a survey of lead colposcopists across England.
Sherman SM; Nailer E; Pearmain P; Todd RW; Redman CW
Cytopathology; 2016 Aug; 27(4):237-41. PubMed ID: 26566859
[TBL] [Abstract][Full Text] [Related]
6. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer in women aged less than 25: East Kent experience.
Nair MS; Bhandari HM; Nordin AJ
J Obstet Gynaecol; 2007 Oct; 27(7):706-8. PubMed ID: 17999298
[TBL] [Abstract][Full Text] [Related]
8. Interval cancer audit and disclosure in cervical screening programmes: An international survey.
Fitzpatrick P; Mooney T; Byrne H; Healy O; Russell N; O'Reilly S
J Med Screen; 2022 Jun; 29(2):104-109. PubMed ID: 34894859
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
12. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
13. Invasive cancer of the cervix: does the UK National Health Service screening programme fail due to patients' non-attendance?
Clement KM; Mansour D
Eur J Gynaecol Oncol; 2013; 34(1):28-30. PubMed ID: 23589995
[TBL] [Abstract][Full Text] [Related]
14. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
16. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
17. Patients with cervical cancer: why did screening not prevent these cases?
de Bie RP; Vergers-Spooren HC; Massuger LF; Siebers AG; Salet-van der Pol MR; Vedder JE; Melchers WJ; Bulten J; Bekkers RL
Am J Obstet Gynecol; 2011 Jul; 205(1):64.e1-7. PubMed ID: 21481838
[TBL] [Abstract][Full Text] [Related]
18. Multifactorial audit of invasive cervical cancer: key lessons for the National Screening Programme.
Slater DN
J Clin Pathol; 1995 May; 48(5):405-7. PubMed ID: 7629283
[TBL] [Abstract][Full Text] [Related]
19. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the nationwide cervical screening programme in Thailand: a case-control study.
Kasinpila C; Promthet S; Vatanasapt P; Sasieni P; Parkin DM
J Med Screen; 2011; 18(3):147-53. PubMed ID: 22045824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
